Stephen Michael Kelsey
CIK 1462808 · See Remarks · last filed 2026-03-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$43.98M
Companies
4
Total Filings
62
Lifetime Open-Market Net
-$19.97M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVMDW | See Remarks | 295,398 | $5.94 | $1.75M | -$14.95M | 24 | 2026-03-19 |
| RVMD | See Remarks | 273,721 | $153.87 | $42.12M | -$4.90M | 23 | 2023-10-13 |
| MEDIVATION, INC. (MDVN) Delisted | SVP of New Projects | 21,000 | — | — | $0 | 3 | 2014-02-20 |
| GERN | EVP, R&D, Chief Med Officer | 94,796 | $1.15 | $109.0K | -$122.9K | 12 | 2013-05-07 |
Recent Filings · Page 7 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-30 | GERN | Sell (S) | −3,707 | -$21.0K | EDGAR |
| 2009-05-20 | GERN | Grant (A) | — | $0 | EDGAR |
Showing 61–62 of 62
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.